Hideaki Imamura
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Microbial Natural Products and Biosynthesis
Papers in
-
- Enzyme Catalysis and Immobilization 6
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 8
- Microbial Natural Products and Biosynthesis 3
- Co-authors
- Hajime Morishima (16 shared papers)Koji Yamada (16 shared papers)Terutaka Hashizume (9 shared papers)Rie Nagano (6 shared papers)Jinsaku Sakakibara (4 shared papers)Tsumoru Morimoto (3 shared papers)Naoki Yamada (3 shared papers)Aya Shimizu (11 shared papers)
- Journals
- Chemical and Pharmaceutical Bulletin (7 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Bioorganic & Medicinal Chemistry (4 papers)Tetrahedron (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- JapanPakistanUnited States
In The Last Decade
Hideaki Imamura
36 papers receiving 419 citations
Peers
Comparison fields: 5 of 74
- Molecular Medicine 105
- Pharmacology 112
- Applied Microbiology and Biotechnology 11
- Organic Chemistry 141
- Nephrology 27
Countries citing papers authored by Hideaki Imamura
This map shows the geographic impact of Hideaki Imamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Imamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Imamura more than expected).
Fields of papers citing papers by Hideaki Imamura
This network shows the impact of papers produced by Hideaki Imamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Imamura. The network helps show where Hideaki Imamura may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideaki Imamura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 62 | |
| 2 | 1991 | 58 | |
| 3 | 1999 | 58 | |
| 4 | 2000 | 26 | |
| 5 | 1994 | 23 | |
| 6 | 2015 | 20 | |
| 7 | 1990 | 19 | |
| 8 | 1998 | 18 | |
| 9 | 2000 | 17 | |
| 10 | 2000 | 15 | |
| 11 | 2015 | 13 | |
| 12 | 2003 | 11 | |
| 13 | 2015 | 10 | |
| 14 | 1997 | 9 | |
| 15 | 2011 | 9 | |
| 16 | 2002 | 8 | |
| 17 | 1991 | 8 | |
| 18 | 2000 | 6 | |
| 19 | 2000 | 6 | |
| 20 | 2020 | 6 |
About Hideaki Imamura
Hideaki Imamura is a scholar working on Molecular Biology, Pharmacology, Organic Chemistry, Molecular Medicine and Epidemiology, having authored 37 papers that have together received 440 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (8 papers), Enzyme Catalysis and Immobilization (6 papers), Synthesis of β-Lactam Compounds (5 papers), Synthesis and Catalytic Reactions (5 papers), Microbial Natural Products and Biosynthesis (3 papers), Synthetic Organic Chemistry Methods (3 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Molecular Medicine (105 citations), Pharmacology (112 citations), Applied Microbiology and Biotechnology (11 citations), Organic Chemistry (141 citations) and Nephrology (27 citations). Hideaki Imamura has collaborated with scholars based in Japan, Pakistan and United States. Frequent co-authors include Hajime Morishima, Koji Yamada, Terutaka Hashizume, Rie Nagano, Jinsaku Sakakibara, Tsumoru Morimoto, Naoki Yamada, Aya Shimizu, Hiroki Sato and Hideki Jona. Their work appears in journals such as Chemical and Pharmaceutical Bulletin, Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Tetrahedron and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.